Editorial: Neuroprotection and Disease Modification in Parkinson's Disease.
作者信息
Otero-Losada Matilde, Gubellini Paolo, Capani Francisco, Perez-Lloret Santiago
机构信息
Centro de Altos Estudios en Ciencias Humanas y de la Salud, Universidad Abierta Interamericana, Consejo Nacional de Investigaciones Científicas y Técnicas, CAECIHS.UAI-CONICET, Buenos Aires, Argentina.
Aix-Marseille University, CNRS, IBDM UMR7288, Parc Scientifique de Luminy, Marseille, France.
出版信息
Front Pharmacol. 2021 Dec 8;12:813471. doi: 10.3389/fphar.2021.813471. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Neuroprotection and Disease Modification in Parkinson's Disease.社论：帕金森病中的神经保护与疾病修饰
Front Pharmacol. 2021 Dec 8;12:813471. doi: 10.3389/fphar.2021.813471. eCollection 2021.
2
Editorial: Neuroprotection and disease modification in Parkinson's disease: Volume II.社论：帕金森病的神经保护与疾病修饰：第二卷
Front Pharmacol. 2023 Jan 9;13:1121513. doi: 10.3389/fphar.2022.1121513. eCollection 2022.
3
Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease.社论：阿尔茨海默病和帕金森病的疾病修饰靶点及策略
Front Aging Neurosci. 2023 Jul 14;15:1247256. doi: 10.3389/fnagi.2023.1247256. eCollection 2023.
4
Neuroprotective strategies in Parkinson's disease : an update on progress.帕金森病的神经保护策略：进展更新
CNS Drugs. 2003;17(10):729-62. doi: 10.2165/00023210-200317100-00004.
5
GardeninA confers neuroprotection against environmental toxin in a Drosophila model of Parkinson's disease.GardeninA 可在帕金森病的果蝇模型中提供针对环境毒素的神经保护作用。
Commun Biol. 2021 Feb 5;4(1):162. doi: 10.1038/s42003-021-01685-2.
6
TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF.星形胶质细胞上的TRPV1通过睫状神经营养因子拯救帕金森病中的黑质多巴胺能神经元。
Brain. 2015 Dec;138(Pt 12):3610-22. doi: 10.1093/brain/awv297. Epub 2015 Oct 21.
7
Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson's disease.鼻腔内富血小板纤维蛋白-内源性修复因子增强帕金森病小鼠模型中的神经元存活并减轻 NF-κB 依赖性炎症过程。
J Control Release. 2015 Apr 10;203:170-80. doi: 10.1016/j.jconrel.2015.02.030. Epub 2015 Feb 20.
8
Clinical trials for neuroprotection in Parkinson's disease: overcoming angst and futility?帕金森病神经保护的临床试验：克服焦虑与徒劳？
Curr Opin Neurol. 2007 Aug;20(4):477-83. doi: 10.1097/WCO.0b013e32826388d6.
9
Role of rasagiline in treating Parkinson's disease: Effect on disease progression.雷沙吉兰在治疗帕金森病中的作用：对疾病进展的影响。
Ther Clin Risk Manag. 2009 Aug;5(4):413-9. doi: 10.2147/tcrm.s4321. Epub 2009 Jun 4.
10
New hopes for disease modification in Parkinson's Disease.帕金森病治疗新希望：疾病修饰
Neuropharmacology. 2020 Jul;171:108085. doi: 10.1016/j.neuropharm.2020.108085. Epub 2020 Apr 13.
本文引用的文献
1
Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial.褪黑素治疗帕金森病快速眼动睡眠行为障碍的随机对照试验。
Mov Disord. 2020 Feb;35(2):344-349. doi: 10.1002/mds.27886. Epub 2019 Oct 31.
2
Protective effect of edaravone on blood-brain barrier by affecting NRF-2/HO-1 signaling pathway.依达拉奉通过影响NRF-2/HO-1信号通路对血脑屏障的保护作用。
Exp Ther Med. 2019 Oct;18(4):2437-2442. doi: 10.3892/etm.2019.7859. Epub 2019 Aug 6.
3
Melatonin: Clinical Perspectives in Neurodegeneration.褪黑素：神经退行性变的临床视角
Front Endocrinol (Lausanne). 2019 Jul 16;10:480. doi: 10.3389/fendo.2019.00480. eCollection 2019.
4
The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson's Disease.酮体D-β-羟基丁酸可能改善帕金森病多种细胞病理学的机制。
Front Nutr. 2019 May 14;6:63. doi: 10.3389/fnut.2019.00063. eCollection 2019.
5
Direct CNS delivery of proteins using thermosensitive liposome-in-gel carrier by heterotopic mucosal engrafting.通过异位黏膜移植，利用热敏脂质体凝胶载体将蛋白质直接递送至中枢神经系统。
PLoS One. 2018 Dec 5;13(12):e0208122. doi: 10.1371/journal.pone.0208122. eCollection 2018.
6
From stroke to neurodegenerative diseases: The multi-target neuroprotective effects of 3-n-butylphthalide and its derivatives.从中风到神经退行性疾病：3-正丁基苯酞及其衍生物的多靶点神经保护作用。
Pharmacol Res. 2018 Sep;135:201-211. doi: 10.1016/j.phrs.2018.08.007. Epub 2018 Aug 11.
7
Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson's disease-like motor dysfunction.黑质多巴胺能神经元上生长激素释放肽受体的下调导致类似帕金森病的运动功能障碍。
Mol Brain. 2018 Feb 20;11(1):6. doi: 10.1186/s13041-018-0349-8.
8
6-Hydroxydopamine induces autophagic flux dysfunction by impairing transcription factor EB activation and lysosomal function in dopaminergic neurons and SH-SY5Y cells.6-羟基多巴胺通过损害多巴胺能神经元和SH-SY5Y细胞中转录因子EB的激活及溶酶体功能，诱导自噬流功能障碍。
Toxicol Lett. 2018 Feb;283:58-68. doi: 10.1016/j.toxlet.2017.11.017. Epub 2017 Nov 21.
9
l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?帕金森病中左旋多巴诱发的异动症：神经炎症和星形胶质细胞是关键因素吗？
Synapse. 2016 Dec;70(12):479-500. doi: 10.1002/syn.21941. Epub 2016 Sep 27.
10
Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action.大麻二酚与辣椒素受体拮抗剂联合使用可减轻小鼠左旋多巴诱导的异动症：可能的作用机制。
Neurobiol Dis. 2016 Oct;94:179-95. doi: 10.1016/j.nbd.2016.06.013. Epub 2016 Jun 29.
Zotero 插件